Unigene names new president and CEO
This article was originally published in Scrip
Ashleigh Palmer has been named president and chief executive officer of Unigene Laboratories (US), replacing Dr Warren Levy. Mr Palmer also becomes a member of Unigene's board of directors. He previously served as CEO of Critical Biologics, where he remains a director, and headed the strategic advisory firm Creative BioVentures. Unigene is a biopharmaceutical company focused on the oral and nasal delivery of large-market peptide drugs.